{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:52:43Z","timestamp":1789869163599,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.hrthm.2024.06.028","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T13:24:39Z","timestamp":1718889879000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold?"],"prefix":"10.1016","volume":"22","author":[{"given":"Leonard A.","family":"Dijkshoorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke","family":"Smeding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Pepplinkhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien A.","family":"de Veld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinoud E.","family":"Knops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2306-603X","authenticated-orcid":false,"given":"Louise R.A.","family":"Olde Nordkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.06.028_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007691","article-title":"Risk factors and temporal trends of complications associated with transvenous implantable cardiac defibrillator leads","volume":"7","author":"Koneru","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.06.028_bib2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/europace\/euu147","article-title":"Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival","volume":"16","author":"Tarakji","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.06.028_bib4","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/01.CIR.0000015508.59749.F5","article-title":"Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS)","volume":"105","author":"Gold","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.06.028_bib5","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.hrthm.2013.05.016","article-title":"Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator","volume":"10","author":"Knops","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jce.14914","article-title":"Outcomes of two versus three incision techniques: results from the subcutaneous ICD post-approval study","volume":"32","author":"El-Chami","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/CIRCEP.123.011867","article-title":"Impact of median sternotomy on safety and efficacy of the subcutaneous implantable cardioverter defibrillator","volume":"16","author":"Sugrue","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/europace\/euad028","article-title":"Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case-control study","volume":"25","author":"Botto","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004663","article-title":"Implantation of the subcutaneous implantable cardioverter-defibrillator: an evaluation of 4 implantation techniques","volume":"10","author":"Brouwer","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/jce.12642","article-title":"Submuscular approach for subcutaneous implantable cardioverter defibrillator: a potential alternative technique","volume":"26","author":"Migliore","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib11","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/europace\/euw297","article-title":"Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications","volume":"19","author":"Winter","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006665","article-title":"Factors associated with high-voltage impedance and subcutaneous implantable defibrillator ventricular fibrillation conversion success","volume":"12","author":"Amin","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.hrthm.2018.09.029","article-title":"A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the PRAETORIAN score","volume":"16","author":"Quast","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131639","article-title":"Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: time to reduce the size of the pulse generator?","volume":"398","author":"van der Stuijt","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2024.02.032","article-title":"Validation of the PRAETORIAN score in a large subcutaneous implantable cardioverter-defibrillator collective: usefulness in clinical routine","author":"Doldi","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.hrthm.2024.02.005","article-title":"Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: a subanalysis of the PRAETORIAN-DFT trial","volume":"21","author":"Knops","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ahj.2019.05.002","article-title":"Rationale and design of the PRAETORIAN-DFT trial: a prospective randomized comparative trial of subcutaneous implantable cardioverter-defibrillator implantation with and without defibrillation testing","volume":"214","author":"Quast","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2024.06.028_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.hrthm.2023.10.004","article-title":"Defibrillation testing of the subcutaneous implantable cardioverter-defibrillator at the time of generator replacement","volume":"21","author":"Schaller","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad184","article-title":"Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement","volume":"25","author":"de Veld","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib20","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/pace.13838","article-title":"Implantation of subcutaneous defibrillator is feasible and safe with monitored anesthesia care","volume":"42","author":"Afzal","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.hrthm.2021.03.008","article-title":"Tumescent local anesthesia versus general anesthesia for subcutaneous implantable cardioverter-defibrillator implantation","volume":"18","author":"Romero","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib22","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.06.028_bib23","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.06.028_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.06.028_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12744","article-title":"Need for pacing in patients who qualify for an implantable cardioverter-defibrillator: clinical implications for the subcutaneous ICD","volume":"25","author":"Kutyifa","year":"2020","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.hrthm.2022.02.029","article-title":"Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: a propensity-matched analysis from a multicenter European registry","volume":"19","author":"Gulletta","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib27","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous implantable cardioverter defibrillator implantations: a randomized, multicenter trial","volume":"175","author":"Healey","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2024.06.028_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacep.2016.02.008","article-title":"Outcomes in patients with congenital heart disease receiving the subcutaneous implantable-cardioverter defibrillator: results from a pooled analysis from the IDE study and the EFFORTLESS S-ICD registry","volume":"2","author":"D'Souza","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib29","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib30","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jce.12705","article-title":"Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis","volume":"26","author":"El-Chami","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib31","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCEP.113.000481","article-title":"Who should receive the subcutaneous implanted defibrillator? The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing","volume":"6","author":"Poole","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ccep.2023.09.002","article-title":"Subcutaneous implantable cardioverter defibrillators in pediatrics and congenital heart disease","volume":"15","author":"Kohli","year":"2023","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hrthm.2024.06.028_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad239","article-title":"Modern subcutaneous implantable defibrillator therapy in patients with cardiomyopathies and channelopathies: data from a large multicentre registry","volume":"25","author":"Migliore","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad270","article-title":"Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator","volume":"25","author":"Francia","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.hrthm.2022.01.013","article-title":"Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy","volume":"19","author":"Jankelson","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad132","article-title":"Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?","volume":"25","author":"Cadrin-Tourigny","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.hrthm.2022.09.016","article-title":"Lights and shadows of subcutaneous implantable cardioverter-defibrillator in Brugada syndrome","volume":"20","author":"Dendramis","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijcard.2018.07.037","article-title":"Evaluation of a novel automatic screening tool for determining eligibility for a subcutaneous implantable cardioverter-defibrillator","volume":"272","author":"Sakhi","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/jce.12343","article-title":"Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening","volume":"25","author":"Olde Nordkamp","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/europace\/eut370","article-title":"How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?","volume":"16","author":"Randles","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib41","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2023.05.057","article-title":"Subcutaneous implantable cardioverter-defibrillators in patients with congenital heart disease","volume":"82","author":"Waldmann","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib42","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/ehf2.13243","article-title":"Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease","volume":"8","author":"Zormpas","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hrthm.2024.06.028_bib43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.hrthm.2020.01.016","article-title":"Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease","volume":"17","author":"Wang","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib44","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/europace\/eux009","article-title":"High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes","volume":"20","author":"Conte","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib45","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/jce.13315","article-title":"Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome","volume":"28","author":"Tachibana","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00380-018-1300-8","article-title":"Prevalence of subcutaneous implantable cardioverter-defibrillator based on template ECG screening and ineligible surface ECG predicting factors in patients with hypertrophic cardiomyopathy in China","volume":"34","author":"Guo","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.hrthm.2024.06.028_bib47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jce.12714","article-title":"Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy","volume":"26","author":"Francia","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacep.2022.09.020","article-title":"Subcutaneous and transvenous defibrillators in arrhythmogenic right ventricular cardiomyopathy: a comparison of clinical and quality-of-life outcomes","volume":"9","author":"Wang","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.06.028_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCULATIONAHA.121.057816","article-title":"Efficacy and safety of appropriate shocks and antitachycardia pacing in transvenous and subcutaneous implantable defibrillators: analysis of all appropriate therapy in the PRAETORIAN trial","volume":"145","author":"Knops","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.06.028_bib51","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.06.028_bib52","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.06.028_bib53","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2401807","article-title":"A modular communicative leadless pacing-defibrillator system","author":"Knops","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.06.028_bib54","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib55","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.06.028_bib56","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.06.028_bib57","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jelectrocard.2018.08.022","article-title":"How the S-ICD (subcutaneous implantable cardiac defibrillator) senses cardiac signals to minimize cardiac over-sensing and maximize rhythm discrimination","volume":"51","author":"Brisben","year":"2018","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad040","article-title":"Exploiting SMART pass filter deactivation detection to minimize inappropriate subcutaneous implantable cardioverter defibrillator therapies: a real-world single-centre experience and management guide","volume":"25","author":"Monkhouse","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euac234","article-title":"Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice","volume":"25","author":"Rordorf","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jce.12612","article-title":"A new algorithm to reduce inappropriate therapy in the S-ICD system","volume":"26","author":"Brisben","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib61","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.hrthm.2013.12.007","article-title":"Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management","volume":"11","author":"Kooiman","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib62","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","article-title":"Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial","volume":"43","author":"Knops","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.06.028_bib63","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.06.028_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/s10840-023-01468-1","article-title":"Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients: insights from a multicenter registry","author":"L\u00fcker","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib65","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.hrthm.2022.03.009","article-title":"Longevity of model 3501 subcutaneous implantable cardioverter-defibrillator leads in clinical practice","volume":"19","author":"Viani","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib66","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijcard.2016.11.017","article-title":"A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator","volume":"228","author":"Honarbakhsh","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib67","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/europace\/euv299","article-title":"The learning curve associated with the introduction of the subcutaneous implantable defibrillator","volume":"18","author":"Knops","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib68","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jacep.2020.05.029","article-title":"First-in-human chronic implant experience of the substernal extravascular implantable cardioverter-defibrillator","volume":"6","author":"Crozier","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib69","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.06.028_bib70","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad301","article-title":"Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter-defibrillator","volume":"25","author":"Crozier","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib71","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib72","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.19102\/icrm.2022.130407","article-title":"Subcutaneous implantable cardioverter-defibrillator explantation\u2014a single tertiary center experience","volume":"13","author":"Pothineni","year":"2022","journal-title":"J Innov Card Rhythm Manag"},{"key":"10.1016\/j.hrthm.2024.06.028_bib73","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/jce.14171","article-title":"Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients","volume":"30","author":"Quast","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib74","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.hrthm.2023.08.009","article-title":"Acute human defibrillation performance of a subcutaneous implantable cardioverter-defibrillator with an additional coil electrode","volume":"20","author":"Yap","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib75","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/europace\/euw258","article-title":"Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey","volume":"18","author":"Boveda","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.06.028_bib76","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","article-title":"Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy","volume":"68","author":"Brouwer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib77","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCEP.112.973339","article-title":"Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience","volume":"5","author":"Aydin","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib78","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/eurheartj\/ehab921","article-title":"Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study","volume":"43","author":"Lambiase","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.06.028_bib79","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/CM9.0000000000000133","article-title":"Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators","volume":"132","author":"Liang","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.hrthm.2024.06.028_bib80","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejim.2017.09.038","article-title":"Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD)\u2014a nationwide multicentre registry","volume":"48","author":"Sponder","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hrthm.2024.06.028_bib81","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jacc.2023.05.034","article-title":"Postapproval study of a subcutaneous implantable cardioverter-defibrillator system","volume":"82","author":"Gold","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.028_bib82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.14740\/cr638w","article-title":"Subcutaneous implantable cardioverter defibrillators implantation without defibrillation threshold testing: a single center experience","volume":"8","author":"Al-Ghamdi","year":"2017","journal-title":"Cardiol Res"},{"key":"10.1016\/j.hrthm.2024.06.028_bib83","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.hrthm.2021.07.008","article-title":"Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: real-world data from the extended ELISIR experience","volume":"18","author":"Gasperetti","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.028_bib84","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1253\/circj.CJ-17-1001","article-title":"Safety and efficacy of subcutaneous cardioverter defibrillator in patients at high risk of sudden cardiac death\u2014primary Japanese experience","volume":"82","author":"Sasaki","year":"2018","journal-title":"Circ J"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124027413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124027413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T04:00:34Z","timestamp":1735790434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124027413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1547527124027413"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.028","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold?","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}